Skip to main content
Clinical Trials/NCT00014482
NCT00014482CompletedNot Applicable

Music Therapy for Distress During Autologous Stem Cell Transplantation: A Randomized Trial

Memorial Sloan Kettering Cancer Center1 site in 1 countryStarted: December 1, 2000Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Locations
1

Study Overview

Brief Summary

RATIONALE: Music therapy may be effective in relieving pain and emotional distress in patients who are undergoing cancer therapy.

PURPOSE: Randomized trial to determine the effectiveness of music therapy to ease pain and emotional distress in patients with hematologic cancer who are undergoing high-dose therapy and stem cell transplantation.

Detailed Description

OBJECTIVES:

  • Compare the effects of music therapy vs no music therapy on depression and anxiety in patients with hematologic malignancies undergoing high-dose therapy and autologous stem cell transplantation.
  • Compare the effects of these regimens on mood, mucositis pain, pain interference, need for analgesic medication, and length of hospital stay of these patients.
  • Compare the immediate effects of these regimens on mood in these patients.

OUTLINE: This is a randomized study. Patients are stratified according to whole body or whole lymphatic irradiation (yes vs no) and diagnosis (non-Hodgkin's lymphoma vs Hodgkin's lymphoma vs myeloma/amyloidosis). Patients are randomized to one of two arms.

  • Arm I: Patients receive individualized music therapy over 20-30 minutes beginning on day 0 and continuing over 16 days for a maximum of 12 sessions during high-dose therapy and autologous stem cell transplantation.

Patients complete a Profile of Mood States (POMS) quality of life and pain questionnaire on days -2, 0, 1, 4, 7, 10, 13, and 16.

Study Design

Study Type
Interventional
Allocation
Randomized

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • DISEASE CHARACTERISTICS:
  • Diagnosis of a hematologic malignancy
  • No leukemia
  • Planned high-dose therapy and autologous stem cell transplantation (HDT/ASCT) at Memorial Sloan-Kettering Cancer Center
  • PATIENT CHARACTERISTICS:
  • 18 and over
  • Performance status:
  • Not specified
  • Life expectancy:
  • Not specified
  • Hematopoietic:
  • Not specified
  • Not specified
  • Not specified
  • PRIOR CONCURRENT THERAPY:
  • Biologic therapy:
  • See Disease Characteristics
  • No prior HDT/ASCT
  • Chemotherapy:
  • See Disease Characteristics
  • Endocrine therapy:
  • Not specified
  • Radiotherapy:
  • Not specified
  • Not specified

Exclusion Criteria

  • Not provided

Investigators

Study Sites (1)

Loading locations...

Similar Trials